CVRX Company Profile and Key Details

CVRX has shown weak momentum, losing -23.53% over the past week and -43.82% over the past quarter, though year-to-date performance is down -21.27%. Short-term trend indicators are bullishly aligned (SMA20 25.42%, SMA50 16.43%, SMA200 5.35%). The stock’s 14-day RSI is 64.66 (firm momentum), while the ATR of 0.7 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -42.51% below its high and over 87.47% above its low. Average 10-day trading volume of 551.66 thousand shares is below the 3-month average of 791.31 thousand, indicating normal recent market interest.

CVRx, Inc. generated EPS of -$2.04 over the past year. Five-year average earnings growth is -22.44%. Wall Street analysts project EPS growth of 6.41% annually over the next five years. The latest quarter delivered EPS of -$0.53. The next quarter is forecast at -$0.52. Next year's EPS is expected at $4.05. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $13.00 to $10.00. The high target offers 337.71% upside. The low target suggests 236.7% downside. The mean target is $11.25. This offers 278.79% upside. CVRx, Inc. earnings surprise history is a mixed track record. The quarter that ended August 06, 2026, missed forecasts by 1.03%. The prior quarter beat by -1.96%. Over the last six quarters, Apple has recorded several small beats. These include -5.36% in May 08, 2025.

CVRx, Inc. has 26.64 million shares outstanding. The public float is 17.01 million shares, elevated short interest at 10.56% of float. This equals 2.01 million shares. The short ratio is 8.21 days. Institutional investors hold 70.25% of the float. Insiders own 9.55%. JOHNSON & JOHNSON holds 4.02 million shares, NEW ENTERPRISE ASSOCIATES 10 L P has 2.03 million shares and Nielsen Kirk G. has 1.91 million shares. Over the past six months, insider transactions show balanced activity. They sold 1.31 thousand shares across 1 transactions.

CVRx, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.18. This means the shares are trading below this model’s fair value.

CVRx, Inc. (NASDAQ:CVRX) closed at $2.97 USD, losing -$0.07 (-2.30%) from the previous close of $3.04. The stock is currently mid-range between its 52-week high and low $2.20 and $11.30. With a market capitalization of about $78.81 million, CVRx, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.76). Key stats such as the average daily volume over the past year has been around 804.27 thousand shares, volume is running light vs its 52-week average. Headquartered in Minneapolis, MN, CVRx, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Kevin Hykes, the company employs approximately 223 people and listed since June 30, 2021. CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases.

CVRx, Inc. trades at a P/E ratio of -1.49, slightly below the S&P 500 average, with a price-to-sales ratio of 1.28 and a price-to-book ratio of 3.92 trading at moderately above to book value. The P/FCF stands at -1.91, also above market averages.

CVRx, Inc. (NASDAQ:CVRX) shares are down -21.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CVRx, Inc. trading at a premium to the broader market with a P/E of -1.49. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $16.21, suggesting 445.79% upside. Our AI forecast model points to short-term weakness (-21.21% over two weeks), a medium-term fall (-70.37% over three months), and a longer-term gain (82.49% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that CVRx, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -21.21%, with price expected at $2.34 by October 02, 2026, within a range of $1.35 to $3.41 3-Month Outlook: Projected fall of -70.37%, reaching $0.88 by December 17, 2026, with a range of $0.59 to $1.15. 1-Year Outlook: Projected gain of 82.49%, with price at $5.42 by September 17, 2027, within a range of $0.00 to $5.47.